Pharmacoepitranscriptomic landscape revealing m6A modification could be a drug-effect biomarker for cancer treatment
RNA chemical modifications are a new but rapidly developing field. They can directly affect RNA splicing, transport, stability, and translation. Consequently, they are involved in the occurrence and development of diseases that have been studied extensively in recent years. However, few studies have...
Main Authors: | Ke Liu, Qian-Ying Ouyang, Yan Zhan, Hui Yin, Bo-Xuan Liu, Li-Ming Tan, Rong Liu, Wei Wu, Ji-Ye Yin |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-06-01
|
Series: | Molecular Therapy: Nucleic Acids |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2162253122000774 |
Similar Items
-
Pan-cancer characterization of m6A-mediated regulation of T cell exhaustion dynamics and clinical relevancies in human cancers
by: Weiping Ji, et al.
Published: (2025-03-01) -
Recent Advances in Identification of RNA Modifications
by: Wei Chen, et al.
Published: (2016-12-01) -
N6-methyladenosine modification contributes to respiratory syncytial virus infection
by: Zhu Li, et al.
Published: (2023-04-01) -
N6-methyladenosine modification in ischemic stroke: Functions, regulation, and therapeutic potential
by: Fei Han
Published: (2024-02-01) -
Interpretable deep cross networks unveiled common signatures of dysregulated epitranscriptomes across 12 cancer types
by: Rong Xia, et al.
Published: (2024-12-01)